Envestnet Asset Management Inc Novo Cure LTD Transaction History

Envestnet Asset Management Inc

$299 Billion
Q1 2025

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$14.54 - $33.41 $133,171 - $306,002	9,159 New	9,159 $272,000
Q3 2023 Nov 13, 2023	BUY	$16.15 - $42.35 $29,619 - $77,669	1,834 Added 17.17%	12,515 $202,000
Q2 2023 Aug 04, 2023	SELL	$40.29 - $82.51 $2.8 Million - $5.73 Million	-69,497 Reduced 86.68%	10,681 $443,000
Q1 2023 May 11, 2023	BUY	$56.44 - $118.81 $3.17 Million - $6.66 Million	56,090 Added 232.85%	80,178 $4.82 Million
Q4 2022 Feb 07, 2023	BUY	$63.98 - $85.37 $176,264 - $235,194	2,755 Added 12.91%	24,088 $1.77 Million
Q3 2022 Nov 10, 2022	SELL	$67.99 - $89.57 $18,969 - $24,990	-279 Reduced 1.29%	21,333 $1.62 Million
Q2 2022 Aug 03, 2022	SELL	$56.6 - $89.9 $199,118 - $316,268	-3,518 Reduced 14.0%	21,612 $1.5 Million
Q1 2022 May 04, 2022	SELL	$60.15 - $84.52 $104,961 - $147,487	-1,745 Reduced 6.49%	25,130 $2.08 Million
Q4 2021 Feb 04, 2022	BUY	$75.08 - $121.99 $61,865 - $100,519	824 Added 3.16%	26,875 $2.02 Million
Q3 2021 Oct 07, 2021	BUY	$116.17 - $194.55 $831,893 - $1.39 Million	7,161 Added 37.91%	26,051 $3.03 Million
Q2 2021 Aug 04, 2021	BUY	$130.4 - $225.58 $370,336 - $640,647	2,840 Added 17.69%	18,890 $4.19 Million
Q1 2021 May 04, 2021	SELL	$124.11 - $190.17 $36,612 - $56,100	-295 Reduced 1.8%	16,050 $2.12 Million
Q4 2020 Feb 02, 2021	BUY	$112.16 - $174.14 $43,742 - $67,914	390 Added 2.44%	16,345 $2.83 Million
Q3 2020 Oct 09, 2020	SELL	$58.05 - $111.31 $67,918 - $130,232	-1,170 Reduced 6.83%	15,955 $1.78 Million
Q2 2020 Jul 08, 2020	BUY	$57.2 - $74.41 $87,516 - $113,847	1,530 Added 9.81%	17,125 $1.02 Million
Q1 2020 Apr 23, 2020	BUY	$57.05 - $95.75 $163,847 - $274,994	2,872 Added 22.57%	15,595 $1.05 Million
Q4 2019 Feb 11, 2020	BUY	$68.3 - $93.8 $94,254 - $129,444	1,380 Added 12.17%	12,723 $1.07 Million
Q3 2019 Oct 17, 2019	SELL	$61.86 - $97.8 $63,035 - $99,658	-1,019 Reduced 8.24%	11,343 $848,000
Q2 2019 Aug 02, 2019	BUY	$42.22 - $63.23 $29,427 - $44,071	697 Added 5.98%	12,362 $782,000
Q1 2019 May 10, 2019	SELL	$31.96 - $56.12 $11,090 - $19,473	-347 Reduced 2.89%	11,665 $562,000
Q4 2018 Feb 13, 2019	BUY	$28.72 - $52.63 $344,984 - $632,191	12,012 New	12,012 $402,000
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $138,368 - $226,577	-4,324 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$19.85 - $32.0 $85,831 - $138,368	4,324 New	4,324 $135,000

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

79.4M

Call Options Held

970K

Put Options Held

118K

Black Rock Inc. New York, NY

12.1M
Shares

$233 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$216 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

8.95M
Shares

$172 Million
0.03% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

5.52M
Shares

$106 Million
8.14% of portfolio
Capital World Investors Los Angeles, CA

5.22M
Shares

$100 Million
0.02% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.01B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account